Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno
Add to Reading List
Document Date: 2018-07-18 19:08:19
Open Document
File Size: 328,56 KB
Share Result on Facebook
PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno